Literature DB >> 7117149

[Reproducibility of blood pressure measurements in hypertensives during and after ergometry].

I W Franz, F W Lohmann.   

Abstract

On repeated measurement hypertensives have greater swings in resting blood pressure than those with normal pressures. In 20 untreated hypertensives (WHO stage I), average age 35.8 years, blood pressures were measured during and after ergometry (50-100 Watt) to see whether there were any variations during the day and whether repeat measurements were affected by adaptation. Blood pressure measurements repeated three times during ergometry, gave good agreement above 1 Watt/kg body weight, with a mean of 203/116 mm Hg at 8 a.m., 200/114 mm Hg at 10 a.m. and 203/113 mm Hg at 4 p.m., although resting blood pressures at times differed significantly. Even in patients with labile or borderline hypertension, blood pressure measurement during and after ergometry without exception made it possible to assign them to the hypertensive range, which would not have been possible or only to a limited extent at rest. Measurement of blood pressure during and after standardised ergometry is thus superior to resting blood pressure measurements in the identification of hypertensives.

Entities:  

Mesh:

Year:  1982        PMID: 7117149     DOI: 10.1055/s-2008-1070133

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN: 0012-0472            Impact factor:   0.628


  2 in total

1.  Elasticity changes in the large arteries of human limbs in response to cycle ergometry performed with upper and lower limbs.

Authors:  B I Mazhbich; M D Roifman
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1989

2.  Exercise blood pressure and the risk of incident cardiovascular disease (from the Framingham Heart Study).

Authors:  Gregory D Lewis; Philimon Gona; Martin G Larson; Jonathan F Plehn; Emelia J Benjamin; Christopher J O'Donnell; Daniel Levy; Ramachandran S Vasan; Thomas J Wang
Journal:  Am J Cardiol       Date:  2008-03-28       Impact factor: 2.778

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.